Baramiya Mamuka G, Baranov Eugene
AntiCancer, Inc., San Diego, CA 92111, USA.
Stemedica Cell Technologies, CA 92121, USA.
Future Sci OA. 2020 Jan 14;6(3):FSO450. doi: 10.2144/fsoa-2019-0119.
Here, we interpret malignant tissue transformation from the aging point of view, that is, as a result of insufficient cell adaptation to the needs of regeneration/repair and proliferation. A consequence of the aging (senescence) process is gradual loss of self-renewal potential. It limits lifespan and leads to death due to the decline of tissue/organ functions, failure of regulatory mechanisms, disruption of endogenous processes and increased susceptibility to exogenous factors. Recapitulation of the embryonic pathway of self-renewal/rejuvenation in adulthood is epigenetically determined. At the postembryonic stage, in the absence of immune privilege, this recapitulation is transformed into cancer (potency expansion of single structures composing the organism to the detriment of the whole organism or disintegrating growth). We suggest that the process of rebirth occurs in the same way as embryonic tissue growth. Thus, the idea to use the potential of the transformed cells to stop the aging process has been proposed.
在此,我们从衰老的角度来解释恶性组织转化,即细胞对再生/修复和增殖需求的适应不足所致。衰老(细胞衰老)过程的一个后果是自我更新潜能逐渐丧失。这限制了寿命,并因组织/器官功能衰退、调节机制失灵、内源性过程紊乱以及对外源性因素易感性增加而导致死亡。成年期自我更新/恢复活力的胚胎途径的重演是由表观遗传学决定的。在胚胎后期阶段,在缺乏免疫特权的情况下,这种重演会转化为癌症(构成生物体的单个结构的潜能扩张,对整个生物体造成损害或生长瓦解)。我们认为重生过程与胚胎组织生长的方式相同。因此,有人提出利用转化细胞的潜能来阻止衰老过程的想法。